In recent years, several groups have reported dominant inheritance of obesity conferred by missense, nonsense and frameshift mutations in the melanocortin 4 receptor gene (MC4R). Hence, MC4R is involved in the most common monogenic form of human obesity described so far. OBJECTIVES: In this context, we screened a Spanish population, composed of obese subjects and normal weight controls, for mutations in the MC4-R by single-strand conformational polymorphism (SSCP). SUBJECTS AND METHODS: Overall 313 individuals, 159 obese subjects (body mass index: BMI: 37.6 kg/m 2 , 95% CI: 36.7-38.5 kg/m 2 ) and 154 normal weight control subjects (BMI: 22.3 kg/m 2 , 95% CI: 22.0-22.6 kg/m 2 ) were screened for MC4-R mutations. RESULTS: We detected a novel nonsense mutation at codon 16 of the MC4-R in an obese female (BMI: 30.0 kg/m 2 ) and a previously described missense mutation (Val-253-Ile) located within the sixth trans-membrane domain of the MC4-R in a normal weight individual (BMI: 19.0 kg/m 2 ). The polymorphism Val-103-Ile was detected in one obese individual, while four subjects (two cases and two controls) with the polymorphism Ile-251-Leu were found. CONCLUSIONS: We have identified a novel nonsense mutation (Trp-16-Stop) that, based on previously described frameshift and nonsense mutations, most likely results in dominantly inherited obesity. Within this Spanish population, the frequency of the Ile-251-Leu polymorphism of the MC4R was similar in obese and control subjects (about 1.3%), while the polymorphism Val-103-Ile was only detected in an obese individual (0.6%).
Introduction
Dominant inheritance of obesity conferred by missense, nonsense and frameshift mutations in the melanocortin 4 receptor gene (MC4R) has been extensively reported in many populations including French, English, German, American and Italian individuals. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Several mutations of the MC4R, mainly one nonsense (Tyr-35-Stop) and three frameshift mutations (732-733insGATT, 631-634delCTCT, 47-48insG) can be considered loss-of-function mutations and are associated with dominant inheritance of obesity. Functional studies showed that many of the missense muations also lead to a loss of function of the MC4R. 5, 6, 8, 13 However, other mutations (ie Thr-11-Ser, Arg-18-Cys) and two polymorphisms (Val-103-Ile, Ile-251-Leu) did not modify the function of the MC4R in vitro. 5, 7 It has been estimated that 2-4% of extremely obese individuals harbor functionally relevant MC4R mutations. 14 In this Spanish study, we assessed mutation rates in 159 obese cases and 154 normal weight controls. The repeated comparison of mutation rates between obese and control study groups is useful for assessing the functional implication of MC4R mutations in the etiology of obesity.
Materials and methods
The study population comprised 313 Spanish subjects, aged 20-60 y and it is based on a case-control design. Cases ) were selected. Controls were healthy subjects having a BMIo25 kg/m 2 with no apparent disease and blood pressure below 120/90. Responses rates were acceptable (65% for cases and 75% for controls) and the interviews were all conducted in a medical enviroment. The study was approved by the Ethics Committee of the University of Navarra and all subjects provided written informed consent for participation. The reported investigation has been carried out according to the principles of the Declaration of Helsinki II. Anthropometric measurements were made by standard procedures and fat mass was measured by bioelectrical impedance. Following a 12 h fast, venous blood samples were obtained and serum glucose and lipids were measured by enzymatic methods. Serum insulin was measured by radioimmunoassay (TK/N1, Diagnostic Product Corporation, Los Angeles-California, USA) and plasma leptin by enzymeimmune assay (EIA-1863, DRG Diagnostics, Germany) as described elsewhere. 15 Blood samples were taken for the extraction and characterization of genomic DNA from leukocytes. Single strand Conformational polymorphism (SSCP) analysis for mutations in the MC4-R was performed as previously reported. 
Results
We identified four different variants: a novel nonsense (Trp-16-Stop) mutation, a previously described missense mutation (Val-253-Ile), as well as two known polymorphisms Val-103-Ile and Ile-251-Leu ( Table 1 ). The clinical characteristics of the MC4R mutation carriers are indicated in Table 2 . The Val-103-Ile polymorphism was detected in one (BMI: 35.4 kg/ m 2 ) out of the 159 obese individuals, while we identified two controls and two obese subjects with the Ile-251-Leu polymorphism.
The obese female heterozygous for the Trp-16-Stop mutation (II2 in Figure 1a ) reported early onset of obesity at age 8. She additionally reported having continuously restricted her energy intake in the sense of being on a constant diet. Her maximum weight was 100 kg (BMI 34.6 kg/m 2 , at age 30 y).
Recently, an abdominal lipectomy was performed for cosmetic reasons. She inherited the mutation from her mother (I2 in Figure 1a ). Her mother reported adolescenct onset of obesity. She has also been continuously attempting to restrict her energy intake, her maximum weight was 80 kg at age 30 y (max BMI: 30.5 kg/m).
Hormone measurements were performed in the index proband. The corticotropic and thyrotropic axe was normal (ACTH ¼ 8. 
Discussion
Here we report for the first time the nonsense mutation Trp-16-Stop in the MC4R. The female index patient is not characterized by any readily detectable phenotypic abnormality other than early onset obesity. She inherited the mutation from her mother, who is also a heterozyous carrier and who has a history of obesity. This novel nonsense III1  II5  II4  II3  II2   13  24  29  34  32  37  53   30  15  24  22  23  22  30 A novel nonsense mutation in the melanocortin-4 receptor A Marti et al.
mutation at codon 16 of the MC4R should lead to a receptor that is truncated at the N-terminal extracellular domain. It resembles the nonsense mutation Tyr-35-Stop, which was also associated with obesity. 3 It is readily evident that the gene products of these two nonsense mutations cannot function based on previous pharmacological characterizations of other nonsense and frameshift mutations. 1, 4 In a normal weight control subject, we detected a previously described missense mutation (Val-253-Ile) that is located within the sixth trans-membrane domain of the MC4R. 4, 7 Presently, few missense variants of MC4R have been described in normal weight individuals.
4,5
The Ile-251-Leu polymorphism was detected in two normal weight and two obese subjects, a similar result was reported by Vaisse et al similar allele frequencies in obese and normal weight subjects. Most of the reports did not find association with obesity. [3] [4] [5] 7, 16 . This corresponds with normal signaling properties of the 103-Ile receptor variant in functional studies. 5, 13 In our study, we only found one obese subject carrier of the Val-103-Ile polymorphism.
In conclusion: (a) a novel nonsense mutation in the MC4R, most likely underlying dominantly inherited obesity, was identified in an obese female; (b) within the Spanish population, the frequency of the Ile-251-Leu polymorphism of the MC4R was similar in obese and normal weight subjects (about 1.3%), while the polymorphism Val-103-Ile was only detected in an obese individual (0.6%). A novel nonsense mutation in the melanocortin-4 receptor A Marti et al.
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